Virtual Medicinal Product (VMP)
-
Alendronic acid 5mg tablets
Name Details
Current Name
Alendronic acid 5mg tablets
|
Start Date
15-12-2002
|
End Date
|
Unit Dose & Form Information
- DF Indicator
- Discrete
- UDFS Indicator
- 1
- UDFS UOM
- tablet
- Unit Dose UOM
- tablet
Summary
- Prescribing Status
- Valid as a prescribable product
- Controlled Drug Category
- No Controlled Drug Status
- Route
- Oral
- Form
- Oral tablet
- Ontology Form/Route
- tablet.oral
- Non-availability Indicator
- Actual Products not Available
- Name Basis
- rINN - Recommended International Non-proprietary
Codes
- ATC Code
-
M05BA04
BNF |
Current BNF
06060200
|
Start Date
04-04-2022
|
End Date
|
Previous BNF
06060200
|
Start Date
25-02-2005
|
End Date
03-04-2022
|
SNOMED Codes
Code
|
Start Date
|
End Date
|
39730811000001107 |
27-05-2021 |
|
325977006 |
15-12-2002 |
26-05-2021 |
VMP Ingredients
Name
Alendronate sodium
Basis of strength description
Based on Base Substance
BOSS
Alendronic acid
Strength and UOM (Nmr)
5
Strength and UOM (Dmr)
Virtual Medicinal Product Pack (VMPP) Information